526
Participants
Start Date
August 31, 2007
Primary Completion Date
October 31, 2007
Study Completion Date
November 30, 2007
0.15% azelastine hydrochloride 1644 mcg daily
0.15% azelastine hydrochloride 1644 mcg daily
0.1% azelastine hydrochloride 1096 mcg daily
0.1% azelastine hydrochloride 1096 mcg daily
Placebo
0 mcg Placebo daily
AAIR Research Center, Rochester
Allergy and Clinical Immunology Associates, Pittsburgh
Allergy and Consultants of NJ/PA, Collegeville
North Carolina Clinical Research, Raleigh
National Allergy, Asthma and Urticaria of Charleston, Charleston
Center of Research Excellence, LLC, Oxford
East Tennesse Center for Clinical Research, Knoxville
Family Allergy and Asthma Reserach, Louisville
Bernstein Clinical Research Center, Cincinnati
Clinical Research Institute, Plymouth
Sneeze, Wheeze and Itch Associates, Normal
ENTA Allergy, Head and Neck Associates, Decatur
Allergy, Asthma and Immunology Associates, Lincoln
Allergy, Asthma and Clinical Research Center, Oklahoma City
Allergy and Asthma Care, Waco
Central Texas Health Research, New Braunfels
Biogenics Research Institute, San Antonio
Sylvana Research Associates, San Antonio
Allergy and Asthma Associates, Austin
Colorado Allergy and Asthma Centers, Denver
Storms Clinical Research Institute, Colorado Springs
Allergy Research Foundation, Los Angeles
Clinical Research Center, Encinitas
Allergy Associates Medical Group Inc, San Diego
Southern California Research, Mission Viejo
Northeast Medical Research Associates, North Dartmouth
Atlantic Research Center, Ocean City
Princeton Center for Clinical Research, Skillman
Research Asthma, Sinus and Allergy Centers, Warren Township
Lead Sponsor
Meda Pharmaceuticals
INDUSTRY